Drawing for PHENOTROPIL

USPTO serial 79046203

PHENOTROPIL

Reviewed by CopyMark Law Group

Reg. 3516704Status 404
Filing date
Status date
Registration date
Oct 14, 2008
Examiner
DWYER, JOHN D
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHENOTROPIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James H. Walters

JAMES WALTERS PATENTTM.USPO BOX 82788PORTLAND, OR 97282-0788UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of mental and neural illness or disorder, illness or disorder connected with stroke; pharmaceutical preparations for the treatment of illness or disorder connected with dysfunctional immunity; with loss of organism resistance to rugged environment; with psychoemotional stress and stresses of different etiology; pharmaceutical preparations for the treatment of illness connected with hearing and visual disorder; pharmaceutical preparations for the treatment of illness connected with peripheric circulation disorder; pharmaceutical preparations for the treatment of sexual disorder and illness connected with the aforesaid; pharmaceutical preparations for the treatment of alcohol, drug and other addictive substances dependence; pharmaceutical preparations for the treatment of social maladjustment; pharmaceutical preparations for the treatment of obesity of different etiology; pharmaceutical preparations for treatment of those exhibiting mental impairment, defective memory, detraction and mental retardation; pharmaceutical preparations meant for increasing organism resistance to infectious and virus diseases; pharmaceutical preparations meant for increasing mental and physical work capacity in extreme conditions of professional activity; pharmaceutical preparations meant for prevention and treatment of hypoxia, illness and disorder connected with hypoxiaSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 6, 2024UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Dec 28, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Dec 28, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 17, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 19, 2016INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 19, 2016INPCINVALIDATION PROCESSED—
Jan 15, 2016INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 11, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 15, 2015C71TCANCELLED SECTION 71—
Jun 13, 2013RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 3, 2010CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jun 26, 2009FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 29, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 29, 2009FIMPFINAL DISPOSITION PROCESSED—
Jan 14, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 14, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 29, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 9, 2008NPUBNOTICE OF PUBLICATION—
Jun 24, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 19, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 18, 2008ALIEASSIGNED TO LIE—
Jun 17, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 10, 2008RFNTREFUSAL PROCESSED BY IB—
Dec 18, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 18, 2007RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2007DOCKASSIGNED TO EXAMINER—
Dec 10, 2007NWAPNEW APPLICATION ENTERED—
Dec 7, 2007LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Dec 6, 2007SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance